These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance? Vogt L; Kocks MJ; Laverman GD; Navis G Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515 [TBL] [Abstract][Full Text] [Related]
30. Renal perfusion and function. The implications of converting enzyme inhibition. Hollenberg NK Am J Med; 1988 Apr; 84(4A):9-15. PubMed ID: 3064608 [TBL] [Abstract][Full Text] [Related]
31. Long-term effects of converting enzyme inhibitors on split renal function in renovascular hypertension. Miyamori I; Yasuhara S; Takeda R Clin Exp Hypertens A; 1987; 9(2-3):629-32. PubMed ID: 3038426 [TBL] [Abstract][Full Text] [Related]
37. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide. Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714 [TBL] [Abstract][Full Text] [Related]